AMEX: SER
Serina Therapeutics, Inc.
Healthcare · Biotechnology
After hours: $2.10(0%) · as of 6:27 PM ET
Market Cap
$22.75M
52w High
$7.92
52w Low
$1.22
P/E
-1.07
Volume
11.76K
Outstanding Shares
10.83M
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock fell 63.29% over the last year. Free cash flow grew 8.3% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently -18,803.08%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain.
Valuation
Stock splits
Every 250 shares became 7
Profitability & growth
Analyst consensus
1
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 7, 2026
Q3 FY26 · EPS est -$0.47 · Revenue est —
View